The most confident conclusion is that ergothioneine is absorbed and concentrated in the body. Evidence for specific health outcomes ranges from preliminary human signals to preclinical hypotheses.
A claim-by-claim approach
“Benefits” is a marketing word; evidence has designs, outcomes and limitations. We rate each topic from controlled human evidence downward and state when a result is observational or preclinical.
- Healthy aging: intriguing animal and cohort findings; no established human longevity effect
- Cognition: observational associations plus one very small randomized pilot
- Cellular protection: substantial mechanistic work; uncertain clinical translation
- Sleep: an early controlled study requires replication
- Skin: one mushroom-product trial with industry involvement
- Cardiovascular outcomes: insufficient controlled human evidence for clinical claims
Why evidence levels can change
An evidence rating is a time-stamped editorial assessment, not a permanent grade. A larger preregistered trial, failed replication or newly identified bias can move confidence up or down.
Educational information only. This page does not provide personalized medical advice.
Read the full disclaimer →